Psagot Investment House Ltd increased Nice (NICE) stake by 3.06% reported in 2018Q1 SEC filing. Psagot Investment House Ltd acquired 4,976 shares as Nice (NICE)’s stock rose 11.00%. The Psagot Investment House Ltd holds 167,631 shares with $15.75 million value, up from 162,655 last quarter. Nice now has $6.46 billion valuation. The stock increased 0.12% or $0.12 during the last trading session, reaching $104.32. About 107,735 shares traded. NICE Ltd. (NASDAQ:NICE) has risen 38.47% since June 29, 2017 and is uptrending. It has outperformed by 25.90% the S&P500. Some Historical NICE News: 11/05/2018 – NICE Actimize Re-lnvents Financial Crime Analytics with Flexible Cloud-Enabled; 17/04/2018 – NICE Actimize Enhances Its Markets Surveillance Solution to Help Firms Comply with MiFlD Il Microsecond Requirement for High Frequency Trading; 08/03/2018 – CallVU Joins NICE inContact DEVone Program to Drive Contact Center Efficiency with Intelligent Self-Service Options; 07/05/2018 – NICE Actimize Named “Best Trade Surveillance Solution for MAD/MAR Technology” Category Winner in A-Team Group’s 2018 RegTech Awards; 27/03/2018 – NICE Receives Highest Product Scores Across All Four Use Cases in Gartner’s Critical Capabilities for Workforce Engagement; 27/03/2018 – NICE Receives Highest Product Scores Across All Four Use Cases in Gartner’s Critical Capabilities for Workforce Engagement Management; 09/05/2018 – NICE to Host Financial Analyst and Investor Day at Interactions 2018; 10/05/2018 – NICE 1Q EPS $0.37; 26/04/2018 – NICE To Acquire Mattersight, Bolstering its Leadership in Cloud Customer Service Analytics; 16/05/2018 – NICE inContact CXone With RiverStar Improves Compliance and Reduces Training Costs and Errors for Appriss Safety
Agenus Inc (NASDAQ:AGEN) had an increase of 4.39% in short interest. AGEN’s SI was 10.74M shares in June as released by FINRA. Its up 4.39% from 10.29M shares previously. With 1.81 million avg volume, 6 days are for Agenus Inc (NASDAQ:AGEN)’s short sellers to cover AGEN’s short positions. The SI to Agenus Inc’s float is 13.64%. The stock decreased 2.38% or $0.055 during the last trading session, reaching $2.255. About 993,017 shares traded. Agenus Inc. (NASDAQ:AGEN) has declined 0.29% since June 29, 2017 and is downtrending. It has underperformed by 12.86% the S&P500. Some Historical AGEN News: 15/05/2018 – Point72 Asset Management Buys New 3.3% Position in Agenus; 17/05/2018 – Agenus to Present Clinical Data on Lead Programs at ASCO 2018; 07/05/2018 – Agenus at Deutsche Bank Health Care Conference Tomorrow; 07/05/2018 – Agenus 1Q Loss/Shr 53c; 19/04/2018 – DJ Agenus Inc, Inst Holders, 1Q 2018 (AGEN); 15/03/2018 Agenus 4Q Loss/Shr 35c; 10/04/2018 – Agenus Presenting at Deutsche Bank Health Care Conference May 8; 07/05/2018 – Agenus 1Q Loss $54.3M; 04/04/2018 – Agenus Presenting at Conference Tomorrow; 15/03/2018 – AGENUS INC – CASH, AND CASH EQUIVALENTS WERE $60.2 MLN AT DECEMBER 31, 2017
More news for Agenus Inc. (NASDAQ:AGEN) were recently published by: Seekingalpha.com, which released: “Corvus Pharmaceuticals Remains A High-Risk Investment” on June 26, 2018. Benzinga.com‘s article titled: “Benzinga’s Daily Biotech Pulse: Epidiolex, Roche’s Influenza Drug Gets Priority Review Status, Xeris Jumps On …” and published on June 26, 2018 is yet another important article.
Agenus Inc., a clinical-stage immuno-oncology company, focuses on the discovery and development of therapies that engage the bodyÂ’s immune system for patients suffering with cancer. The company has market cap of $234.52 million. The firm offers Retrocyte Display, an antibody discovery platform for the identification of fully-human and humanized monoclonal antibodies; SECANT yeast display, an antibody discovery platform used for the generation of novel monoclonal antibodies; and phage display technologies. It currently has negative earnings. It is also developing checkpoint modulating antibody candidates targeting GITR, OX40, TIM-3, and LAG-3.
Investors sentiment increased to 1.46 in 2018 Q1. Its up 0.20, from 1.26 in 2017Q4. It improved, as 11 investors sold Agenus Inc. shares while 24 reduced holdings. 20 funds opened positions while 31 raised stakes. 46.47 million shares or 27.93% more from 36.32 million shares in 2017Q4 were reported. Great West Life Assurance Company Can holds 8,800 shares or 0% of its portfolio. Sg Americas Ltd Liability has invested 0% in Agenus Inc. (NASDAQ:AGEN). Voya Investment Mgmt holds 0% of its portfolio in Agenus Inc. (NASDAQ:AGEN) for 36,185 shares. Vident Invest Advisory Limited Liability Company holds 484,930 shares or 0.09% of its portfolio. 156,500 are held by Swiss Bankshares. Vanguard Group invested in 0% or 3.64M shares. Chicago Equity Prns Limited Liability invested in 214,675 shares. Bluecrest Management stated it has 10,341 shares. The Georgia-based Atlantic Tru Gru Ltd Liability Corp has invested 0% in Agenus Inc. (NASDAQ:AGEN). Tiaa Cref Investment Limited Liability reported 0% in Agenus Inc. (NASDAQ:AGEN). Weiss Multi holds 0.01% or 50,000 shares in its portfolio. Jacobs Levy Equity Mgmt holds 0% of its portfolio in Agenus Inc. (NASDAQ:AGEN) for 10,700 shares. Rhumbline Advisers holds 70,996 shares. Ubs Asset Mgmt Americas reported 0% in Agenus Inc. (NASDAQ:AGEN). Art Advsrs Limited Liability Com reported 0% of its portfolio in Agenus Inc. (NASDAQ:AGEN).
More notable recent NICE Ltd. (NASDAQ:NICE) news were published by: Businesswire.com which released: “NICE Actimize Innovates Approach to Real-Time P2P Payments with Market Leading Fraud Essentials Cloud Solutions” on June 26, 2018, also Globes.Co.Il with their article: “Nice Systems boycotts El Al over treatment of women” published on June 26, 2018, Globes.Co.Il published: “Sun: Banks lift TASE” on June 24, 2018. More interesting news about NICE Ltd. (NASDAQ:NICE) were released by: Nasdaq.com and their article: “Detailed Research: Economic Perspectives on Central European Media Enterprises, Valeant Pharmaceuticals …” published on June 05, 2018 as well as Businesswire.com‘s news article titled: “NICE Actimize Scores Two Wins as Financial Crime and Market Surveillance Products of the Year in 2018 Risk …” with publication date: June 20, 2018.
Psagot Investment House Ltd decreased Spdr S&P (Xhb (XHB) stake by 301,661 shares to 37,604 valued at $1.53M in 2018Q1. It also reduced Pfizer (Pfe) (NYSE:PFE) stake by 9,305 shares and now owns 173,930 shares. Ishares (Acwi) (ACWI) was reduced too.
The post Psagot Investment House LTD Lifted By $462,768 Its Nice (NICE) Stake; Shorts at Agenus (AGEN) Raised By 4.39% appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2018/06/29/psagot-investment-house-ltd-lifted-by-462768-its-nice-nice-stake-shorts-at-agenus-agen-raised-by-4-39/